The miR-200 family, miR-183 and miR-21 have been shown to target the PTEN gene, and their expression levels in endometrial tissue can be used to predict the risk of tumor progression from endometrial hyperplasia to invasive EC [102,122]. The gene discussed is PTEN; the disease is neoplasm.